External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
Standard
External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection. / Hansen, Jens; Rink, Michael; Bianchi, Marco; Kluth, Luis A; Tian, Zhe; Ahyai, Sascha A; Shariat, Shahrokh F; Briganti, Alberto; Steuber, Thomas; Fisch, Margit; Graefen, Markus; Karakiewicz, Pierre I; Chun, Felix K-H.
in: PROSTATE, Jahrgang 73, Nr. 2, 2, 2013, S. 211-218.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
AU - Hansen, Jens
AU - Rink, Michael
AU - Bianchi, Marco
AU - Kluth, Luis A
AU - Tian, Zhe
AU - Ahyai, Sascha A
AU - Shariat, Shahrokh F
AU - Briganti, Alberto
AU - Steuber, Thomas
AU - Fisch, Margit
AU - Graefen, Markus
AU - Karakiewicz, Pierre I
AU - Chun, Felix K-H
N1 - Copyright © 2012 Wiley Periodicals, Inc.
PY - 2013
Y1 - 2013
N2 - PURPOSE: We aimed to test accuracy and generalizability of a recently updated nomogram to assess the probability of lymph node invasion (LNI), when applied to a different European cohort of men undergoing radical prostatectomy (RP) with extended pelvic lymph node dissection (ePLND).MATERIALS AND METHODS: The study cohort consisted of 1,282 men with clinically localized PCa who underwent RP and ePLND, including removal of obturator, external iliac, and hypogastric lymph nodes, between 01/2007 and 08/2011. Descriptive measurements included preoperative clinical and biopsy variables, such as prostate-specific antigen (PSA), clinical stage (CS), primary and secondary biopsy Gleason pattern, and percentage of positive cores. We used the area under curve (AUC) of the receiver operator characteristic analysis to quantify accuracy of the model to predict LNI. The extent of over- or under-estimation was explored graphically within loess calibration plots.RESULTS: The median number of removed lymph nodes was 15 with an interquartile range of 12-20. Twelve percent (n = 155) of men had LNI. Preoperative clinical and biopsy characteristics differed significantly (all P ≤ 0.002) between men with LNI and those without. External validation of the previously reported updated LNI nomogram showed very good accuracy (AUC: 0.829). A nomogram-derived cut-off of 4% could lead to a reduction of 48% of lymph node dissection, while missing 10% of patients with LNI.CONCLUSIONS: We report the external validation of an updated LNI nomogram, demonstrating accuracy and applicability in a different European cohort. A nomogram-derived cut-off of 4% confirmed good performance characteristics within a different external validation cohort.
AB - PURPOSE: We aimed to test accuracy and generalizability of a recently updated nomogram to assess the probability of lymph node invasion (LNI), when applied to a different European cohort of men undergoing radical prostatectomy (RP) with extended pelvic lymph node dissection (ePLND).MATERIALS AND METHODS: The study cohort consisted of 1,282 men with clinically localized PCa who underwent RP and ePLND, including removal of obturator, external iliac, and hypogastric lymph nodes, between 01/2007 and 08/2011. Descriptive measurements included preoperative clinical and biopsy variables, such as prostate-specific antigen (PSA), clinical stage (CS), primary and secondary biopsy Gleason pattern, and percentage of positive cores. We used the area under curve (AUC) of the receiver operator characteristic analysis to quantify accuracy of the model to predict LNI. The extent of over- or under-estimation was explored graphically within loess calibration plots.RESULTS: The median number of removed lymph nodes was 15 with an interquartile range of 12-20. Twelve percent (n = 155) of men had LNI. Preoperative clinical and biopsy characteristics differed significantly (all P ≤ 0.002) between men with LNI and those without. External validation of the previously reported updated LNI nomogram showed very good accuracy (AUC: 0.829). A nomogram-derived cut-off of 4% could lead to a reduction of 48% of lymph node dissection, while missing 10% of patients with LNI.CONCLUSIONS: We report the external validation of an updated LNI nomogram, demonstrating accuracy and applicability in a different European cohort. A nomogram-derived cut-off of 4% confirmed good performance characteristics within a different external validation cohort.
KW - Humans
KW - Male
KW - Aged
KW - Middle Aged
KW - Cohort Studies
KW - Lymphatic Metastasis
KW - Predictive Value of Tests
KW - Retrospective Studies
KW - Nomograms
KW - Lymph Node Excision/methods/standards
KW - Pelvis/pathology/surgery
KW - Prostatic Neoplasms/diagnosis/surgery
KW - Humans
KW - Male
KW - Aged
KW - Middle Aged
KW - Cohort Studies
KW - Lymphatic Metastasis
KW - Predictive Value of Tests
KW - Retrospective Studies
KW - Nomograms
KW - Lymph Node Excision/methods/standards
KW - Pelvis/pathology/surgery
KW - Prostatic Neoplasms/diagnosis/surgery
U2 - 10.1002/pros.22559
DO - 10.1002/pros.22559
M3 - SCORING: Journal article
C2 - 22821742
VL - 73
SP - 211
EP - 218
JO - PROSTATE
JF - PROSTATE
SN - 0270-4137
IS - 2
M1 - 2
ER -
